Call +44 800 9755 164

Public tenders for healthcare in Budapest Hungary

Find all Healthcare tenders in the world.
Finding business opportunities has never been easier.

Results for healthcare. Make a new search!

Medical imaging services

XIII.ker. Egészségügyi Szolgálat Közhasznú Nonprofit Kft. | Published February 24, 2017  -  Deadline April 7, 2017
cpvs
85150000

47 / c. building at no. 

The total operating cost and risk borne by the concessionaire Centre.

The contract in case of unilateral termination notice period, the Parties stipulates five months, during which time eligible for the concessions required to perform a treaty.

In addition to the above, among the operating costs of the concessionaire bears in particular the following costs: medical specialists and operators of the Centre intends to apply the use of cost; performing a CT-MR Center developed self-service front desk "administrator" application of cost; hazardous waste removal and disposal; CT-MR Centre of cleaning and disinfection, the clinic at the time of ordering any additional costs outside of opening hours (ie. required for weekend or night time patients receive additional guarding fees).

Beyond the warranty period, maintenance and bug fixes (including the necessary pipe replacement and helium replacement costs) borne by the concession holder.

CT equipment: GE Healthcare Revolution 128 HD slice.

Concessionaire must also provide data to the contracting authority as specified in the draft contract.

All failed to be paid (commenced) month default penalty, calculated at the time of the unlawful termination of a joint charge monthly amount.

§ 134 (5) of Art. the deadline should be based on the availability of collateral required to declare the offer.

Smart card readers

Állami Egészségügyi Ellátó Központ | Published February 18, 2017  -  Deadline February 27, 2017
cpvs
30233300

The present acquisition of 90 000 pieces of acquisition (+ 20% option) card reader devices for the healthcare industry.

The device for the treatment of contactless cards with contacts and traditional card readers, PIN hardware keyboard.

The acquisition includes a detailed description of the subject matter of the procurement documents Volume V.

Vaccines

Országos Tisztifőorvosi Hivatal | Published February 21, 2017  -  Deadline March 9, 2017
cpvs
33651600, 33651630

BCG vaccine within the framework of the purchase contract of sale.

contracting framework contract for the sale of BCG vaccine obtains - inoculating infants ATC code: J07AN01

In case arising under the contract temporary product shortage delivery bidder vaccine may recommend a replacement for the transitional period in question, the terms of the offering and acceptance contains a draft of the sales contract.

Quantity: 250 000 doses of infant

Packaging: pack offered by the supplier.

If the pre-filled syringes offered product, but needle-free packages, it must be accompanied by a performance of the contract when the vaccine matched, offered by WHO type 2 needle.

If the offered product must be accompanied ampoule packages, the contract has been made for administration, offered by WHO type 2 syringes and needles.

Quality Requirements: The vaccine must comply with the WHO TRS 979: Recommendation to assure the quality, safety and efficacy of BCG Vaccines; European Pharmacopoeia 01/2012: 0163 monograph requirements.

If the performance necessary to ensure the achievement of usability, regardless of the date of 14 months from the date of entry specified by the contracting authority.

Entry deadline:

06/01/2017. - 100 000 doses of babies.

08/01/2017. - 50 000 babies dose.

09/01/2017. - 100 000 doses of babies.

Performance contracting to accept.

During delivery of the vaccine given date, the total amount of overdue entry into the new place of delivery, during storage of the vaccine injection given due date, the total volume of traffic to be able to provide the contracting authority made available as appropriate.

Marketing Authorisation:

Offered vaccines must have forg.-authorization, as follows: should the offer be attached to the pharmaceutical administrative authority (Food and Drug Administration Food and Health Institute, that OGYE or previously Pharmaceutical Healthcare Quality and Development Institute, that GYEMSZI or formerly National pharmaceutical Institute, that NIP) made or issued by the European Commission under Regulation 726/2004 / EC of the European Parliament and the Council, az1901 / 2006 / EC and Regulation 1394/2007 / EC of the European Parliament and of the Council of the European Parliament and the Council, a simple copy of the market for the offered vaccine marketing authorization, if necessary by a translation.

Vaccines

Országos Tisztifőorvosi Hivatal | Published January 26, 2017  -  Deadline February 27, 2017
cpvs
33651600, 33651610, 33651680, 33651640

connection with the acquisition of vaccines, sales of 3 years (2017-2019). For years contract.

Combined sales agreement within the framework of contracting diphtheria, tetanus and pertussis vaccine acquires, adolescents and adults booster doses of the following conditions:

Quantity: 220 000 doses of the basic volumes + 50% option.

Discussion within the total quantity of raw and options can be varied, and the contracting assume any obligation to exercise the option expense amount based on the negotiations or the total quantity is optional.

ATC code: J07AJ52.

Packaging: pack offered by the supplier - in terms of primary packaging in a single dose - pack sizes.

If the pre-filled syringes offered product, but needle-free packages, the contract must be accompanied by the performance of the vaccine fitting offered by the WHO type 2 needle.

If the offered product must be accompanied ampoule packages, the contract has been made for administration, offered by the WHO type 2 syringes and needles.

Quality Requirements: The vaccine must comply with:

- WHO TRS 980: Recommendations to assure the quality, safety and efficacy of combined vaccines DT-based;

- WHO TRS 979: Recommendations to assure the quality, safety and efficacy of acellular pertussis vaccines;

- European Pharmacopoeia 07/2014: 2764 monograph requirements.

If the performance needed to ensure usability, regardless of the date for completion within 24 months from the date specified by the contracting authority added.

Entry deadline:

06/01/2017 .: 110 000 doses.

06/01/2018. 55 000 doses.

06/01/2019 .: 55 000 doses.

The storage times may vary during the negotiations, base and option volume in the total quantity of change in storage further dates will be specified during the negotiations.

During delivery of the vaccine given date, the total amount of overdue entry into the new place of delivery as appropriate.

During storage of the vaccine injection given due date, the total volume of traffic to be able to provide the contracting authority made available as appropriate.

Marketing Authorisation:

should the pharmaceutical administrative authority (Pharmacy and Food-Health Institute, that OGYE or previously Pharmaceutical Healthcare Quality and Development Institute, that GYEMSZI or earlier and Drug Administration, that NIP) The offered vaccines have or by the European Commission in 726 / 2004 / EC of the European Parliament and of the Council az1901 / 2006 / EC or issued pursuant to Regulation 1394/2007 / EC of the European Parliament and of the Council, entry on the offered vaccine marketing authorization, which is easy to copy, where appropriate, the European Parliament and of the Council It must be accompanied by a translation in the offer.

Please note that the contracting OGYE check the website of the product for marketing authorization of its annexes - Summary of Product Characteristics, package leaflet, labeling - the existence and contents.

If the annexes to the offered product for marketing authorization - Summary of Product Characteristics, package leaflet, labeling - in electronic form, the Hungarian language in their entirety, free of charge are not available in OGYE website, please attach to these Hungarian translation.

II.2.4) Description of the procurement:

within the framework of contracting hepatitis B vaccine purchase contract obtains, school vaccination campaign for the following conditions:

Quantity: 400 000 doses of the basic volumes + 65% option.

Discussion within the total quantity of raw and options can be varied, and the contracting assume any obligation to exercise the option debit the amount on the basis of the negotiations, or the total quantity is optional.

ATC code: J07BC01.

Packaging: offered by the supplier - in terms of primary packaging in a single dose - pack sizes.

If the pre-filled syringes offered product, but needle-free packages, the contract must be accompanied by the performance of the vaccine fitting offered by the WHO type 2 needle.

If the offered product must be accompanied packaged ampoule, the contracts the performance of the vaccine fitting offered by the WHO type 2 and 1 syringe needle.

Quality Requirements: The vaccine must meet the

Proposed replacement of: TRS 786, Annex 2 and TRS 889, Annex 4 (2010) and TRS 978;

- European Pharmacopoeia 07/2011: 1056 monograph requirements.

If the performance necessary to ensure the achievement of usability, regardless of the date of 30 months from the date specified by the contracting authority added.

Entry deadline: </

  • 1